Costa Rica vs Panama: Previously treated cases tested for RR-/MDR-TB
Costa Rica
62.0%
in 2024
Panama
61.0%
in 2022
Costa Rica rank
135th
Panama rank
136th
Previously treated cases tested for RR-/MDR-TB over time
- Costa Rica
- Panama
How they compare
Costa Rica currently reports 62.0% against 61.0% in Panama, a difference of 1.0%.
The two have swapped places 6 times across 13 shared years of data; in 2005 it was Panama ahead.
Costa Rica ranks 135th and Panama ranks 136th of 180 countries.
Across the 3 decades both report, Costa Rica averaged higher in 2 and Panama in 1.
Head to head by decade
| Decade | Costa Rica | Panama | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 51.1% | 10.6% | 40.5% | Costa Rica |
| 2010s | 39.3% | 35.4% | 4.0% | Costa Rica |
| 2020s | 28.5% | 64.5% | 36.0% | Panama |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Costa Rica or Panama?
- Costa Rica, at 62.0% against 61.0% in Panama as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Costa Rica and Panama?
- 1.0%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Panama?
- 13 years are reported by both, from 2005 to 2022.
- How do Costa Rica and Panama rank globally for previously treated cases tested for rr-/mdr-tb?
- Costa Rica ranks 135th and Panama ranks 136th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.